Pfizer Inc. PFE Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Young John D

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

39

Price:

$37.18
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Johnson Rady A

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

19

Price:

$37.18
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Damico Jennifer B.

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

144

Price:

$37.18
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Bourla Albert

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

50

Price:

$37.18
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Smith James C

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

1,138

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Quincey James

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

968

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Narayen Shantanu

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

1,273

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Echevarria Joseph

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

1,172

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Young John D

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

12

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Johnson Rady A

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

4

Price:

$36.81

Filings by filing date

Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Young John D

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

39

Price:

$37.18
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Johnson Rady A

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

19

Price:

$37.18
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Damico Jennifer B.

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

144

Price:

$37.18
Jan 12, 2021 (filed on Jan 13, 2021)

Insider Name:

Bourla Albert

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

50

Price:

$37.18
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Smith James C

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

1,138

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Quincey James

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

968

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Narayen Shantanu

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

1,273

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Echevarria Joseph

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

1,172

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Young John D

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

12

Price:

$36.81
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Johnson Rady A

Ownership Type:

Direct Ownership

Securities:

Phantom Stock Units SSP

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

4

Price:

$36.81

News

Biz Brief

Sector: Healthcare	Industry: Pharmaceuticals

See Regulatory Filings on SEC

Company Contact

Address:	235 E 42ND ST NEW YORK NY 10017-5703
Tel:	N/A
Website:	https://www.pfizer.com
IR:	See website

Key People

Albert Bourla Chairman of the Board, Chief Executive Officer	Sally Susman Chief Corporate Affairs Officer, Executive Vice President	John D. Young Chief Business Officer, Group President
Frank A. D'Amelio Chief Financial Officer, Executive Vice President - Business Operations and Global Supply	Angela Hwang Group President, Pfizer Biopharmaceuticals Group	Dawn Rogers Chief Human Resource Officer, Executive Vice President
Lidia Fonseca Executive Vice President, Chief Technology Officer and Digital Officer	Rady A. Johnson Chief Compliance, Quality and Risk Officer, Executive Vice President	Douglas M. Lankler Executive Vice President, General Counsel
Alexander R. Mackenzie Executive Vice President, Chief Development Officer

Business Overview

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Financial Overview

For the nine months ended 27 September 2020, PfizerInc. revenues decreased 8% to $35.96B. Net incomeapplicable to common stockholders excluding extraordinaryitems decreased 46% to $9.02B. Revenues reflect Biopharmasegment decrease of 65% to $10.22B, Upjohn segment decreaseof 76% to $1.92B, United States segment decrease of 69% to$5.72B, Developed Europe segment decrease of 72% to $2.09B.

Employees:	88,300 as of Dec 31, 2019

Reporting Currency:	U.S. Dollars
Enterprise value:	$255,477M as of Sep 27, 2020
Annual revenue (TTM):	$48,648M as of Sep 27, 2020
EBITDA (TTM):	$16,930M as of Sep 27, 2020
Net annual income (TTM):	$8,364M as of Sep 27, 2020
Free cash flow (TTM):	$1,997M as of Sep 27, 2020
Net Debt Last Fiscal Year:	$52,649M as of Sep 27, 2020
Shares outstanding:	5,559,962,916 as of Nov 13, 2020
Index Membership:	S&P 500
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Pfizer Inc. (N:PFE)